Haemonetics Corp. HAE

Haemonetics Corporation is a healthcare company that offers a range of medical products and solutions to help reduce the cost of healthcare while improving patient care around the world. Founded in 1971, Haemonetics has its headquarters in Boston, Massachusetts.

Haemonetics' products address important medical markets, including hospital transfusion services, the surgical suite, and blood and plasma component collection. The company operates through three segments, including Hospital, Blood Center, and Plasma. Through the company's Hospital segment, the company provides patient care, while the Blood Center segment offers solutions for improving the ability of donation collection centres to acquire, filter, and separate blood and its components. Haemonetics' Plasma segment offers solutions to improve the donor experience at donation centres, including donor management software and automated plasma collection systems.

Haemonetics stock is listed on the NYSE under the ticker HAE. The company markets and sells its products to a range of healthcare-related organisations, including blood collection groups, independent blood centres, hospitals and hospital service providers, biopharmaceutical companies, national health organisations, and group purchasing organisations. In January 2021, Haemonetics announced that it had reached an agreement to acquire the privately held Cardiva Medical, Inc., a manufacturer of vascular closure systems in a cash deal for $475m, with an additional payment of up to $35m contingent on sales growth.

Get the latest news and HAE share price updates by adding it to your eToro watchlist.